Response to Commentary on “Predictors of Mortality After Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction”

Abstract

Get full access to this article

View all access options for this article.

References

Yasin

Burak

Fatih

. Predictors of mortality after percutaneous coronary intervention in patients with acute myocardial infarction. Angiology. 2019;70(7):672.

Sun

Chen

Wang

. Contrast-induced nephropathy and long-term mortality after percutaneous coronary intervention in patients with acute myocardial infarction. Angiology. 2019;70(7):621–6.

Peterson

Dai

DeLong

; NCDR Registry Participants. Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry. J Am Coll Cardiol. 2010;55(18):1923–32.

Khera

Kolte

Palaniswamy

. ST-elevation myocardial infarction in the elderly—temporal trends in incidence, utilization of percutaneous coronary intervention and outcomes in the United States. Int J Cardiol. 2013;168(4):3683–90.

de Mulder

Gitt

van Domburg

. EuroHeart score for the evaluation of in-hospital mortality in patients undergoing percutaneous coronary intervention. Eur Heart J. 2011;32(11):1398–408.

Celik

Ozturk

Akin

. Association between contrast media volume-glomerular filtration rate ratio and contrast induced acute kidney injury after primary percutaneous coronary intervention. Angiology. 2015;66(6):519–24.

Neumann

Sousa-Uva

. 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J. 2018;39(42):3759.